Clinical Trial Update: Interest of Plasma microRNAs

View source ↗

Summary

The study explored plasma microRNAs as potential biomarkers in septic shock, and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Septic Shock | Status: COMPLETED